Cmp pharma, inc. private company information – bloomberg gas zombies

#

CMP Pharma, Inc., a specialty pharmaceutical company, develops, manufactures, and markets a portfolio of branded and generic prescription, non-prescription, and skin care pharmaceutical drugs to hospital, long-term care, and retail markets. It offers various prescription products, including those that treat metabolic and dermatological conditions, as well as products that treat Mycobacterium tuberculosis infections; and non-prescription line that includes semi-solid and liquid products, which aid in reducing uncomfortable symptoms of digestive and dermatological ailments. The company provides Simethicone, an OTC agent that is used to reduce bloating and discomfort associated with gas in the …

CMP Pharma, Inc., a specialty pharmaceutical company, develops, manufactures, and markets a portfolio of branded and generic prescription, non-prescription, and skin care pharmaceutical drugs to hospital, long-term care, and retail markets. It offers various prescription products, including those that treat metabolic and dermatological conditions, as well as products that treat Mycobacterium tuberculosis infections; and non-prescription line that includes semi-solid and liquid products, which aid in reducing uncomfortable symptoms of digestive and dermatological ailments. The company provides Simethicone, an OTC agent that is used to reduce bloating and discomfort associated with gas in the stomach and intestinal tract; S orbitol Solution that is used as a conveniently packaged pharmaceutical vehicle; Sodium Polystyrene Sulfonate suspensions; Isoniazid Oral Solution, USP, a liquid form of Isoniazid product; and Oracit, a sodium citrate/citric acid that is used for the treatment of metabolic acidosis and the long-term maintenance of uric acid and cystine calculi of the urinary tract. It also offers Triamcinolone Acetonide 0.05% in Absorbase, a topical corticosteroid, which is used as an anti-inflammatory and anti-pruritic agent; hydrocortisone ointment that is used for the temporary relief of itching associated with minor skin irritations, inflammation, and rashes; and Sodium polystyrene sulfonate powders for the treatment of hyperkalemia. The company serves a range of therapeutic markets, including tuberculosis, hyperkalemia, contact dermatitis, metabolic acidosis, and influenza. CMP Pharma, Inc. was formerly known as Carolina Medical Products Company, Inc. and changed its name to CMP Pharma, Inc. in April 2014. The company was incorporated in 1975 and is based in Farmville, North Carolina.

CMP Pharma announced that CaroSpir® (Spironolactone Oral Suspension, 25 mg/5 mL), the first and only FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone, is now available. CaroSpir was approved by the FDA on August 4, 2017 and is now available through normal retail distribution. CaroSpir oral suspension ensures that adult patients who have difficulty swallowing, or who cannot swallow tablets, receive a stable and consistent dose of spironolactone every time. Until now, patients who have required a liquid form of spironolactone have had to rely on unapproved pharmacy compounded formulations, which typically have limited shelf life, are not quality control tested for potency and sterility/bioburden, and are typically not reimbursed by insurance companies. With FDA approved CaroSpir, the challenges around short-term shelf life and lack of quality control of compounded spironolactone liquids are addressed. CaroSpir is available in 118mL and 473 mL bottles, both of which have 24-month dating and are manufactured and tested at CMP Pharma‘s FDA inspected GMP manufacturing facility in North Carolina. CaroSpir comes in banana flavor to improve compliance. It does not have a black box warning, nor does it have any special handling or storage requirements.